{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:43:34Z","timestamp":1772653414105,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":46,"publisher":"Springer New York","isbn-type":[{"value":"9781493988846","type":"print"},{"value":"9781493988853","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8885-3_4","type":"book-chapter","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T15:30:29Z","timestamp":1542814229000},"page":"57-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expansion and Adoptive Transfer of Human V\u03b42+ T Cells to Assess Antitumor Effects In Vivo"],"prefix":"10.1007","author":[{"given":"Akshat","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Zumwalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny E.","family":"Gumperz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"issue":"6089","key":"4_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/323638a0","volume":"323","author":"P Moingeon","year":"1986","unstructured":"Moingeon P, Ythier A, Goubin G, Faure F, Nowill A, Delmon L, Rainaud M, Forestier F, Daffos F, Bohuon C et al (1986) A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature 323(6089):638\u2013640. https:\/\/doi.org\/10.1038\/323638a0","journal-title":"Nature"},{"issue":"10","key":"4_CR2","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.145.10.3202","volume":"145","author":"E Sturm","year":"1990","unstructured":"Sturm E, Braakman E, Fisch P, Vreugdenhil RJ, Sondel P, Bolhuis RL (1990) Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells. J Immunol 145(10):3202\u20133208","journal-title":"J Immunol"},{"issue":"5","key":"4_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.171.5.1567","volume":"171","author":"P Fisch","year":"1990","unstructured":"Fisch P, Malkovsky M, Braakman E, Sturm E, Bolhuis RL, Prieve A, Sosman JA, Lam VA, Sondel PM (1990) Gamma\/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. J Exp Med 171(5):1567\u20131579","journal-title":"J Exp Med"},{"issue":"21","key":"4_CR4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/jnci\/83.21.1564","volume":"83","author":"AS Ensslin","year":"1991","unstructured":"Ensslin AS, Formby B (1991) Comparison of cytolytic and proliferative activities of human gamma delta and alpha beta T cells from peripheral blood against various human tumor cell lines. J Natl Cancer Inst 83(21):1564\u20131569","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4_CR5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","volume":"96","author":"V Kunzmann","year":"2000","unstructured":"Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M (2000) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96(2):384\u2013392","journal-title":"Blood"},{"issue":"2","key":"4_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2141.2007.06754.x","volume":"139","author":"M Burjanadze","year":"2007","unstructured":"Burjanadze M, Condomines M, Reme T, Quittet P, Latry P, Lugagne C, Romagne F, Morel Y, Rossi JF, Klein B, Lu ZY (2007) In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma. Br J Haematol 139(2):206\u2013216. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06754.x","journal-title":"Br J Haematol"},{"issue":"2","key":"4_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12032-007-9004-4","volume":"25","author":"A Saitoh","year":"2008","unstructured":"Saitoh A, Narita M, Watanabe N, Tochiki N, Satoh N, Takizawa J, Furukawa T, Toba K, Aizawa Y, Shinada S, Takahashi M (2008) Anti-tumor cytotoxicity of gammadelta T cells expanded from peripheral blood cells of patients with myeloma and lymphoma. Med Oncol 25(2):137\u2013147. https:\/\/doi.org\/10.1007\/s12032-007-9004-4","journal-title":"Med Oncol"},{"issue":"6","key":"4_CR8","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.4049\/jimmunol.0903454","volume":"184","author":"M D'Asaro","year":"2010","unstructured":"D'Asaro M, La Mendola C, Di Liberto D, Orlando V, Todaro M, Spina M, Guggino G, Meraviglia S, Caccamo N, Messina A, Salerno A, Di Raimondo F, Vigneri P, Stassi G, Fournie JJ, Dieli F (2010) V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. J Immunol 184(6):3260\u20133268. https:\/\/doi.org\/10.4049\/jimmunol.0903454","journal-title":"J Immunol"},{"issue":"3","key":"4_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3324\/haematol.2010.029520","volume":"96","author":"MS Braza","year":"2011","unstructured":"Braza MS, Klein B, Fiol G, Rossi JF (2011) Gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Haematologica 96(3):400\u2013407. https:\/\/doi.org\/10.3324\/haematol.2010.029520","journal-title":"Haematologica"},{"issue":"9","key":"4_CR10","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.4049\/jimmunol.1103710","volume":"188","author":"J Gertner-Dardenne","year":"2012","unstructured":"Gertner-Dardenne J, Castellano R, Mamessier E, Garbit S, Kochbati E, Etienne A, Charbonnier A, Collette Y, Vey N, Olive D (2012) Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J Immunol 188(9):4701\u20134708. https:\/\/doi.org\/10.4049\/jimmunol.1103710","journal-title":"J Immunol"},{"issue":"20","key":"4_CR11","first-page":"5610","volume":"52","author":"V Malkovska","year":"1992","unstructured":"Malkovska V, Cigel FK, Armstrong N, Storer BE, Hong R (1992) Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency. Cancer Res 52(20):5610\u20135616","journal-title":"Cancer Res"},{"issue":"3","key":"4_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000053824","volume":"125","author":"J Chen","year":"2001","unstructured":"Chen J, Niu H, He W, Ba D (2001) Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes. Int Arch Allergy Immunol 125(3):256\u2013263","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"4_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/ijc.1198","volume":"92","author":"BJ Zheng","year":"2001","unstructured":"Zheng BJ, Chan KW, Im S, Chua D, Sham JS, Tin PC, He ZM, Ng MH (2001) Anti-tumor effects of human peripheral gammadelta T cells in a mouse tumor model. Int J cancer 92(3):421\u2013425","journal-title":"Int J cancer"},{"issue":"1","key":"4_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.CAN-03-1501","volume":"64","author":"F Lozupone","year":"2004","unstructured":"Lozupone F, Pende D, Burgio VL, Castelli C, Spada M, Venditti M, Luciani F, Lugini L, Federici C, Ramoni C, Rivoltini L, Parmiani G, Belardelli F, Rivera P, Marcenaro S, Moretta L, Fais S (2004) Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 64(1):378\u2013385","journal-title":"Cancer Res"},{"issue":"11","key":"4_CR15","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.4049\/jimmunol.173.11.6767","volume":"173","author":"D Kabelitz","year":"2004","unstructured":"Kabelitz D, Wesch D, Pitters E, Zoller M (2004) Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo. J Immunol 173(11):6767\u20136776","journal-title":"J Immunol"},{"issue":"4","key":"4_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","volume":"26","author":"Z Xiang","year":"2014","unstructured":"Xiang Z, Liu Y, Zheng J, Liu M, Lv A, Gao Y, Hu H, Lam KT, Chan GC, Yang Y, Chen H, Tsao GS, Bonneville M, Lau YL, Tu W (2014) Targeted activation of human Vgamma9Vdelta2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease. Cancer Cell 26(4):565\u2013576. https:\/\/doi.org\/10.1016\/j.ccr.2014.07.026","journal-title":"Cancer Cell"},{"issue":"2","key":"4_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bjh.12090","volume":"160","author":"MS Braza","year":"2013","unstructured":"Braza MS, Klein B (2013) Anti-tumour immunotherapy with Vgamma9Vdelta2 T lymphocytes: from the bench to the bedside. Br J Haematol 160(2):123\u2013132. https:\/\/doi.org\/10.1111\/bjh.12090","journal-title":"Br J Haematol"},{"issue":"1","key":"4_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/cmi.2012.39","volume":"10","author":"JJ Fournie","year":"2013","unstructured":"Fournie JJ, Sicard H, Poupot M, Bezombes C, Blanc A, Romagne F, Ysebaert L, Laurent G (2013) What lessons can be learned from gammadelta T cell-based cancer immunotherapy trials? Cell Mol Immunol 10(1):35\u201341. https:\/\/doi.org\/10.1038\/cmi.2012.39","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"4_CR19","first-page":"81","volume":"28","author":"S Buccheri","year":"2014","unstructured":"Buccheri S, Guggino G, Caccamo N, Li Donni P, Dieli F (2014) Efficacy and safety of gammadeltaT cell-based tumor immunotherapy: a meta-analysis. J Biol Regul Homeost Agents 28(1):81\u201390","journal-title":"J Biol Regul Homeost Agents"},{"issue":"5732","key":"4_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes M, Willimann K, Moser B (2005) Professional antigen-presentation function by human gammadelta T Cells. Science 309(5732):264\u2013268. https:\/\/doi.org\/10.1126\/science.1110267","journal-title":"Science"},{"issue":"3","key":"4_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/CJI.0b013e31819b7c30","volume":"32","author":"S Landmeier","year":"2009","unstructured":"Landmeier S, Altvater B, Pscherer S, Juergens H, Varnholt L, Hansmeier A, Bollard CM, Moosmann A, Bisping G, Rossig C (2009) Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer. J Immunother 32(3):310\u2013321. https:\/\/doi.org\/10.1097\/CJI.0b013e31819b7c30","journal-title":"J Immunother"},{"issue":"7","key":"4_CR22","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","volume":"106","author":"M Brandes","year":"2009","unstructured":"Brandes M, Willimann K, Bioley G, Levy N, Eberl M, Luo M, Tampe R, Levy F, Romero P, Moser B (2009) Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci U S A 106(7):2307\u20132312. https:\/\/doi.org\/10.1073\/pnas.0810059106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00262-011-1111-6","volume":"61","author":"B Altvater","year":"2012","unstructured":"Altvater B, Pscherer S, Landmeier S, Kailayangiri S, Savoldo B, Juergens H, Rossig C (2012) Activated human gammadelta T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens. Cancer Immunol Immunother 61(3):385\u2013396. https:\/\/doi.org\/10.1007\/s00262-011-1111-6","journal-title":"Cancer Immunol Immunother"},{"issue":"1408","key":"4_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1098\/rstb.2000.0784","volume":"356","author":"DJ Moss","year":"2001","unstructured":"Moss DJ, Burrows SR, Silins SL, Misko I, Khanna R (2001) The immunology of Epstein-Barr virus infection. Philos Trans R Soc Lond Ser B Biol Sci 356(1408):475\u2013488","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD (2015) The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol 33:787\u2013821. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112326","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"4_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/jcp.53.4.248","volume":"53","author":"P Hopwood","year":"2000","unstructured":"Hopwood P, Crawford DH (2000) The role of EBV in post-transplant malignancies: a review. J Clin Pathol 53(4):248\u2013254","journal-title":"J Clin Pathol"},{"issue":"6","key":"4_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/CCO.0000000000000119","volume":"26","author":"J Sanz","year":"2014","unstructured":"Sanz J, Andreu R (2014) Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation. Curr Opin Oncol 26(6):677\u2013683. https:\/\/doi.org\/10.1097\/CCO.0000000000000119","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"4_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1172\/JCI76357","volume":"125","author":"SD Ma","year":"2015","unstructured":"Ma SD, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, Asimakopoulos F, Tang W, Gulley ML, Cesarman E, Gumperz JE, Kenney SC (2015) LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. J Clin Invest 125(1):304\u2013315. https:\/\/doi.org\/10.1172\/JCI76357","journal-title":"J Clin Invest"},{"issue":"5","key":"4_CR29","doi-asserted-by":"publisher","first-page":"e1005642","DOI":"10.1371\/journal.ppat.1005642","volume":"12","author":"SD Ma","year":"2016","unstructured":"Ma SD, Xu X, Jones R, Delecluse HJ, Zumwalde NA, Sharma A, Gumperz JE, Kenney SC (2016) PD-1\/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model. PLoS Pathog 12(5):e1005642. https:\/\/doi.org\/10.1371\/journal.ppat.1005642","journal-title":"PLoS Pathog"},{"key":"4_CR30","doi-asserted-by":"publisher","unstructured":"Zumwalde NA, Sharma A, Xu X, Ma S, Schneider CL, Romero-Masters JC, Hudson AW, Gendron-Fitzpatrick A, Kenney SC, Gumperz JE (2017) Adoptively transferred Vgamma9Vdelta2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model. JCI Insight 2 (13). https:\/\/doi.org\/10.1172\/jci.insight.93179","DOI":"10.1172\/jci.insight.93179"},{"issue":"17","key":"4_CR31","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1073\/pnas.91.17.8175","volume":"91","author":"Y Tanaka","year":"1994","unstructured":"Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin RL, Brenner MB, Bloom BR, Morita CT (1994) Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A 91(17):8175\u20138179","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/1074-7613(95)90178-7","volume":"3","author":"CT Morita","year":"1995","unstructured":"Morita CT, Beckman EM, Bukowski JF, Tanaka Y, Band H, Bloom BR, Golan DE, Brenner MB (1995) Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 3(4):495\u2013507","journal-title":"Immunity"},{"issue":"3","key":"4_CR33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4049\/jimmunol.154.3.998","volume":"154","author":"JF Bukowski","year":"1995","unstructured":"Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H (1995) V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 154(3):998\u20131006","journal-title":"J Immunol"},{"issue":"1","key":"4_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.161.1.286","volume":"161","author":"JF Bukowski","year":"1998","unstructured":"Bukowski JF, Morita CT, Band H, Brenner MB (1998) Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells. J Immunol 161(1):286\u2013293","journal-title":"J Immunol"},{"issue":"9","key":"4_CR35","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2665","volume":"14","author":"S Vavassori","year":"2013","unstructured":"Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, El Daker S, Beddoe T, Theodossis A, Williams NK, Gostick E, Price DA, Soudamini DU, Voon KK, Olivo M, Rossjohn J, Mori L, De Libero G (2013) Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells. Nat Immunol 14(9):908\u2013916. https:\/\/doi.org\/10.1038\/ni.2665","journal-title":"Nat Immunol"},{"issue":"3","key":"4_CR36","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.4049\/jimmunol.1300658","volume":"191","author":"H Wang","year":"2013","unstructured":"Wang H, Henry O, Distefano MD, Wang YC, Raikkonen J, Monkkonen J, Tanaka Y, Morita CT (2013) Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vgamma2Vdelta2 T cells. J Immunol 191(3):1029\u20131042. https:\/\/doi.org\/10.4049\/jimmunol.1300658","journal-title":"J Immunol"},{"issue":"4","key":"4_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","volume":"40","author":"A Sandstrom","year":"2014","unstructured":"Sandstrom A, Peigne CM, Leger A, Crooks JE, Konczak F, Gesnel MC, Breathnach R, Bonneville M, Scotet E, Adams EJ (2014) The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vgamma9Vdelta2 T cells. Immunity 40(4):490\u2013500. https:\/\/doi.org\/10.1016\/j.immuni.2014.03.003","journal-title":"Immunity"},{"issue":"10","key":"4_CR38","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.4049\/jimmunol.1500314","volume":"195","author":"H Wang","year":"2015","unstructured":"Wang H, Morita CT (2015) Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vgamma2Vdelta2 T Cells. J Immunol 195(10):4583\u20134594. https:\/\/doi.org\/10.4049\/jimmunol.1500314","journal-title":"J Immunol"},{"issue":"5","key":"4_CR39","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.4049\/jimmunol.1401064","volume":"194","author":"DA Rhodes","year":"2015","unstructured":"Rhodes DA, Chen HC, Price AJ, Keeble AH, Davey MS, James LC, Eberl M, Trowsdale J (2015) Activation of human gammadelta T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. J Immunol 194(5):2390\u20132398. https:\/\/doi.org\/10.4049\/jimmunol.1401064","journal-title":"J Immunol"},{"issue":"9","key":"4_CR40","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/eji.201444712","volume":"44","author":"F Riano","year":"2014","unstructured":"Riano F, Karunakaran MM, Starick L, Li J, Scholz CJ, Kunzmann V, Olive D, Amslinger S, Herrmann T (2014) Vgamma9Vdelta2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6. Eur J Immunol 44(9):2571\u20132576. https:\/\/doi.org\/10.1002\/eji.201444712","journal-title":"Eur J Immunol"},{"issue":"1","key":"4_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.imlet.2014.05.011","volume":"161","author":"E Decaup","year":"2014","unstructured":"Decaup E, Duault C, Bezombes C, Poupot M, Savina A, Olive D, Fournie JJ (2014) Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVgamma9+ gammadelta T lymphocytes. Immunol Lett 161(1):133\u2013137. https:\/\/doi.org\/10.1016\/j.imlet.2014.05.011","journal-title":"Immunol Lett"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60761-849-2_4","volume":"691","author":"M Slaoui","year":"2011","unstructured":"Slaoui M, Fiette L (2011) Histopathology procedures: from tissue sampling to histopathological evaluation. Methods Mol Biol 691:69\u201382. https:\/\/doi.org\/10.1007\/978-1-60761-849-2_4","journal-title":"Methods Mol Biol"},{"issue":"9","key":"4_CR43","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.bbmt.2013.06.007","volume":"19","author":"JL Lockridge","year":"2013","unstructured":"Lockridge JL, Zhou Y, Becker YA, Ma S, Kenney SC, Hematti P, Capitini CM, Burlingham WJ, Gendron-Fitzpatrick A, Gumperz JE (2013) Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. Biol Blood Marrow Transplant 19(9):1310\u20131322. https:\/\/doi.org\/10.1016\/j.bbmt.2013.06.007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"4_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/JVI.01512-10","volume":"85","author":"SD Ma","year":"2011","unstructured":"Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML, Tang W, Gumperz JE, Kenney SC (2011) A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 85(1):165\u2013177. https:\/\/doi.org\/10.1128\/JVI.01512-10","journal-title":"J Virol"},{"issue":"15","key":"4_CR45","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1128\/JVI.00770-12","volume":"86","author":"SD Ma","year":"2012","unstructured":"Ma SD, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, Tang W, Burlingham WJ, Gulley ML, Kenney SC (2012) An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol 86(15):7976\u20137987. https:\/\/doi.org\/10.1128\/JVI.00770-12","journal-title":"J Virol"},{"issue":"2","key":"4_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.celrep.2013.09.012","volume":"5","author":"MH Tsai","year":"2013","unstructured":"Tsai MH, Raykova A, Klinke O, Bernhardt K, Gartner K, Leung CS, Geletneky K, Sertel S, Munz C, Feederle R, Delecluse HJ (2013) Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5(2):458\u2013470. https:\/\/doi.org\/10.1016\/j.celrep.2013.09.012","journal-title":"Cell Rep"}],"container-title":["Methods in Molecular Biology","Cancer Immunosurveillance"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8885-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T10:37:05Z","timestamp":1694083025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8885-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"ISBN":["9781493988846","9781493988853"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8885-3_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]}}}